pharmaphorum
JULY 28, 2022
Alnylam Pharma has made a name for itself, developing gene-silencing therapies for rare disorders, but its latest discovery could take it into a much larger category – metabolic and cardiovascular disease.
The Pharma Data
APRIL 11, 2023
Both small molecule inhibitors in Immuno-Oncology are being jointly developed in a strategic research alliance with the German Cancer Research Center (DKFZ) in Heidelberg, Germany. The company has the passion and determination to develop innovative medicines that help improve and extend the lives of people living with cancer.
The Pharma Data
JANUARY 21, 2021
Louis developed a simple and rapid blood test that can predict patients at highest risk of most severe COVID-19 complications or death. They found on average that mitochondrial DNA levels were about tenfold higher in the patients who developed severe lung issues and eventual death. Here’s a look at some of the more interesting ones.
Expert insights. Personalized for you.
52 
Let's personalize your content